It is notable that the drugs acting on this pathway enhance mutant huntingtin clearance via an mTOR-independent autophagy pathway, decrease mutant huntingtin aggregate levels and confer protection against toxicity in HD cell, fly and zebrafish models [24,77]. The gene discussed is MTOR; the disease is Huntington disease.